BR0303489A - Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound - Google Patents
Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compoundInfo
- Publication number
- BR0303489A BR0303489A BR0303489A BR0303489A BR0303489A BR 0303489 A BR0303489 A BR 0303489A BR 0303489 A BR0303489 A BR 0303489A BR 0303489 A BR0303489 A BR 0303489A BR 0303489 A BR0303489 A BR 0303489A
- Authority
- BR
- Brazil
- Prior art keywords
- ether compound
- degradation
- fluorine ether
- inhibiting
- inhibit
- Prior art date
Links
Abstract
"COMPOSIçãO FARMACêUTICA ESTABILIZADA DE COMPOSTO FLúOR-éTER E MéTODO PARA INIBIR A DEGRADAçãO DE COMPOSTO FLúOR-éTER. USO DE AGENTE ESTABILIZANTE PARA INIBIR A DEGRADAçãO DE COMPOSTO FLúOR éTER". A presente invenção tem como objetivo a estabilização de um composto flúor-éter contra a degradação proporcionada por ácidos de Lewis. Os estabilizantes empregados são selecionados dentre compostos farmacêuticos apropriados e são utilizados no preparo de composições farmacêuticas estabilizadas de um composto flúor-éter. São também descritos método de inibir a degradação de um composto flúor-éter e uso de agentes estabilizantes para inibir a degradação de um composto flúor-éter."STABILIZED PHARMACEUTICAL COMPOSITION OF FLUOR-ETHER COMPOUND AND METHOD FOR INHIBITING FLUOR-ETHER COMPOSITE DEGRADATION. USE OF STABILIZING AGENT TO INHIBIT FLUOR ETHER COMPOSITE DEGRADATION". The present invention aims at stabilizing a fluorine ether compound against the degradation provided by Lewis acids. The stabilizers employed are selected from the appropriate pharmaceutical compounds and are used in the preparation of stabilized pharmaceutical compositions of a fluorine ether compound. Also described are methods of inhibiting the degradation of a fluorine ether compound and use of stabilizing agents to inhibit the degradation of a fluorine ether compound.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0303489A BR0303489A (en) | 2003-09-10 | 2003-09-10 | Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound |
PT04737744T PT1663186E (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
PCT/BR2004/000156 WO2005023175A2 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
JP2006525578A JP4253343B2 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of anesthesia fluoroether compound, method for stabilizing fluoroether compound, use of stabilizer to prevent degradation of fluoroether compound |
CN2004800211331A CN1997360B (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether com |
ES04737744T ES2289524T3 (en) | 2003-09-10 | 2004-08-20 | STABLE PHARMACEUTICAL COMPOSITION OF A FLUOROETER COMPOSITE FOR ANESTHETIC USE, PROCEDURE FOR STABILIZING A FLUOROETER COMPOUND, USE OF A STABILIZING AGENT TO AVOID THE DEGRADATION OF A FLUOROETER COMPOUND. |
AT04737744T ATE365034T1 (en) | 2003-09-10 | 2004-08-20 | STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZING AGENT TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND |
EP04737744A EP1663186B1 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
US10/566,466 US7816409B2 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
DE602004007149T DE602004007149T2 (en) | 2003-09-10 | 2004-08-20 | A STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZER TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND |
MXPA06000803A MXPA06000803A (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound. |
PL04737744T PL1663186T3 (en) | 2003-09-10 | 2004-08-20 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
HK07113847.1A HK1108633A1 (en) | 2003-09-10 | 2007-12-19 | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0303489A BR0303489A (en) | 2003-09-10 | 2003-09-10 | Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0303489A true BR0303489A (en) | 2005-07-05 |
Family
ID=34230439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0303489A BR0303489A (en) | 2003-09-10 | 2003-09-10 | Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1997360B (en) |
BR (1) | BR0303489A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2244737T3 (en) * | 2008-01-22 | 2019-07-08 | Univ Texas | Volatile anesthetic compositions comprising extraction solvents for regional anesthesia and / or pain relief |
CN107950565B (en) * | 2017-12-18 | 2021-06-29 | 青岛农业大学 | Pesticide composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5990176A (en) * | 1997-01-27 | 1999-11-23 | Abbott Laboratories | Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
DE60232178D1 (en) * | 2001-08-29 | 2009-06-10 | Pharmakodex Ltd | DEVICE FOR TOPICAL ADMINISTRATION |
GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
-
2003
- 2003-09-10 BR BR0303489A patent/BR0303489A/en not_active Application Discontinuation
-
2004
- 2004-08-20 CN CN2004800211331A patent/CN1997360B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1997360A (en) | 2007-07-11 |
CN1997360B (en) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0508579A (en) | compound, pharmaceutical composition, and use of a compound | |
WO2007145991A3 (en) | Anti-inflammatory and analgesic compositions and related methods | |
BRPI0415121A (en) | particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form | |
BRPI0612104A8 (en) | compound, diastereomeric mixture, pharmaceutical composition, and method for treating hepatitis c infections in a patient and for treating hcv infections in a patient | |
BRPI0509708A (en) | pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and / or medium chain triglycerides | |
EA200802166A1 (en) | STABLE PHARMACEUTICAL COMPOSITION WITH PROTECTIVE ACTION AGAINST IRRITATION (OPTIONS), METHOD FOR ITS PREPARATION AND METHOD OF TREATING CALCIUM MIMETIC WITH IT WITH HELP | |
BRPI0518781A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, and use of a compound | |
HK1108633A1 (en) | Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound | |
MY197773A (en) | Highly concentrated pharmaceutical formulations comprising anti-cd20 antibody | |
MX2009003735A (en) | Injectable depot composition and its' process of preparation. | |
WO2006113631A3 (en) | Bioenhanced compositions | |
BRPI0418270A (en) | methods of treatment and control, treatment or prevention, control of a central nervous system disorder, and to reduce or prevent an adverse effect, and, pharmaceutical composition | |
PE20100265A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION | |
WO2005044234A3 (en) | Nanoparticulate compositions having a peptide as a surface stabilizer | |
EP1750862A4 (en) | Pharmaceutical composition containing irbesartan | |
BRPI0416260A (en) | method for treating, preventing or controlling an asbestos-related disease or disorder and pharmaceutical composition | |
BR112022024943A2 (en) | EFERVESCENT ORAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT | |
PE20080204A1 (en) | PHARMACEUTICAL FORMULATIONS THAT INCLUDE AN ANTICHOLINERGIC AND A BETA AGONIST | |
ES2184310T3 (en) | SELF-EMULSIONING FORMULATION FOR LIPOFIL ACID COMPOUNDS | |
BRPI0514250A (en) | use of a compound, pharmaceutical composition comprising the same, compounds and method of treatment | |
MX2009003794A (en) | Stabilized prostaglandin e composition. | |
DK1635792T3 (en) | Stable pharmaceutical compositions of 2-aza-bicyclo-3.3.0-octane-3-carboxylic acid derivatives | |
BRPI0407652A (en) | method for enhancing the effectiveness of an active agent, composition and method for producing the composition | |
WO2014178789A9 (en) | Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients | |
BR0303489A (en) | Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: BASEADO NO ART. 216 1 DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA. |
|
B11K | Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved |
Free format text: REFERENCIA: PRIORIDADE INTERNA DO PI 0405842-9. |